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Abstract
Genistein, a natural isoflavone present in soybeans, is a potent agent in the prophylaxis and treatment of cancer. Addition of genistein to
isolated rat liver mitochondria (RLM) induces swelling, loss of membrane potential and release of accumulated Ca2 +. These changes are
Ca2 +-dependent and are prevented by cyclosporin A (CsA) and bongkrekic acid (BKA), two classical inhibitors of the mitochondrial
permeability transition (MPT). Induction of the MPT by genistein is accompanied by oxidation of thiol groups and pyridine nucleotides. The
reducing agent dithioerythritol and the alkylating agent N-ethylmaleimide (NEM) completely prevent the opening of the transition pore,
thereby emphasizing that the effect of the isoflavone correlates with the mitochondrial redox state. Further analyses showed that genistein
induces the MPT by the generation of reactive oxygen species (ROS) due to its interaction with the respiratory chain at the level of
mitochondrial complex III.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Genistein, a natural isoflavone (Fig. 1), occurs in plants
and, in particular, is a major component of soybeans. It has
been shown to have anti-tumor, anti-oxidant and anti-
inflammatory effects. Genistein is also able to modulate
cell cycling and to prevent cancer in many different organ
systems [1], most likely by attenuating cytokine-stimulated
proliferation [2]. In addition, it has beneficial effects in
treatment of chronic disorders such as osteoporosis and
cardiovascular diseases and is also successfully used as an
immunosuppressant [3,4]. Very recently, it has been
reported that genistein is a potent inhibitor of a-glucosi-
dase [5]. This and other glucosidases are known to be
involved in a variety of metabolic disorders and other
diseases such as diabetes [6] and cancer [7] as well as in
viral attachment [8]. It is believed that the consumption of
large quantities of soy in Asian countries contributes to the
low incidence of these chronic disorders and that it might
play an important role in promotion of human health [4].
Many studies have identified numerous enzyme targets of
its inhibitory action in living cells [3]. For example,
genistein is a well-known inhibitor of tyrosine kinases
[9], and many of its effects have been attributed to its
alteration of tyrosine kinase-dependent signal transduction
processes. Recently, it has been proposed that genistein
induces apoptosis in RPE-J cells by provoking mitochon-
drial alterations characteristic of mitochondrial permeabil-
ity transition (MPT) induction [10], a key phenomenon in
cell death by apoptosis and necrosis [11,12]. This hypoth-
esis contrasts with a study showing that several flavonoids
are able to inhibit lipid peroxidation and consequently
block the MPT according to their radical-scavenging action
and/or antioxidant potential [13]. In reality, the behaviour
of flavonoids is complex: they could act as either antiox-
idants or prooxidants, depending on their concentration,
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free radical source and presence of transition metals [14].
Indeed, some flavonoids can auto-oxidize in solution with
the production of anion superoxide, hydrogen peroxide and
hydroxyl radicals (ROS) [14–16].
The aim of this study was to elucidate the role of
genistein as a possible inducer of the MPT and to gain
information regarding its mechanism of action.
2. Materials and methods
2.1. Chemicals
Genistein was purchased from Calbiochem and dissolved
in DMSO. All other reagents were of the highest purity
commercially available.
2.2. Mitochondrial preparations
Rat liver mitochondria (RLM) were isolated by conven-
tional differential centrifugation in a buffer containing 250
mM sucrose, 5 mM Hepes (pH 7.4) and 1 mM EDTA [17];
EDTA was omitted from the final washing solution. Protein
content was measured by the biuret method with bovine
serum albumin as a standard [18].
2.3. Standard incubation procedures
Mitochondria (1 mg protein/ml) were incubated in a
water-jacketed cell at 20 jC. The standard medium con-
tained 200 mM sucrose, 10 mM Hepes (pH 7.4), 5 mM
succinate and 1.25 AM rotenone. Variations and/or other
additions are given with the individual experiments pre-
sented. The control assays contained the same volume of
DMSO as those carried out with genistein; the final DMSO
concentration was less than 0.2% (v/v) and did not affect the
assayed activities.
2.4. Determination of mitochondrial functions
Membrane potential was calculated on the basis of the
movements of the lipid-soluble cation tetraphenylphospho-
nium (TPP+) through the inner membrane, measured using a
TPP+-specific electrode prepared according to Kamo et al.
[19]. Mitochondrial swelling was determined by the change
in the absorbance of mitochondrial suspensions at 540 nm
Fig. 1. The structure of genistein.
Fig. 2. Mitochondrial swelling induced by genistein in isolated RLM. RLM were incubated in standard medium supplemented with 30 AM Ca2 + under the
conditions indicated in Materials and methods. A downward deflection indicates mitochondrial swelling. Genistein was added at the concentrations (nmol/mg
prot.) indicated to the right of the curves. The inset shows the effect of CsA (1 AM) and BKA (5 AM) on the swelling induced by 50 AM genistein. The assays
were performed seven times with comparable results.
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using a Kontron Uvikon model 922 spectrophotometer
equipped with thermostatic control. Ca2 + movements were
followed using a Ca2 +-selective electrode (Radiometer
F2112) and a calomel reference electrode (Radiometer
K401). The redox state of endogenous pyridine nucleotides
was followed fluorometrically in an Aminco-Bowman 4-
8202 spectrofluorometer with excitation at 354 nm and
emission at 462 nm. In addition, for quantitative measure-
ments and to exclude the possibility that the fluorescence
change could be influenced by the parallel decrease in light
scattering, pyridine nucleotide oxidation was also deter-
mined by the methylethylketone method [20]. The protein
sulfhydryl oxidation assay was performed as in Santos et al.
[13].
The production of H2O2 in mitochondria was measured
fluorometrically according to Matsumoto et al. [21]. In
brief, mitochondria were incubated in the presence of
horseradish peroxidase (9 U/ml) and 0.9 mM homovanillic
Fig. 3. Collapse of membrane potential (A) and Ca2 + efflux (B) induced by genistein. RLM were incubated as in Fig. 1 with genistein added at the indicated
concentrations. The insets show the effect of 1 AM CsA and 5 AM BKA on DW collapse (panel A) and Ca2 + efflux (panel B) induced by 50 AM genistein.
DE = electrode potential. Five additional experiments exhibited the same trend.
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acid. At intervals of time, aliquots of the incubation
mixture were withdrawn and combined with 0.1 M NaOH.
The fluorescence was then evaluated using an Aminco
Bowman spectrofluometer with excitation at 324 nm and
emission at 426 nm. Fluorimetric calibration curves were
prepared under the same experimental conditions using
serial dilutions of H2O2 in the absence or presence of 1
mg/ml mitochondria.
3. Results
Addition of genistein to a mitochondrial suspension
incubated in the presence of 30 AM Ca2 + provokes a
dose-dependent change in the apparent absorbance that is
indicative of large amplitude swelling (Fig. 2). The max-
imum rate and extent of swelling are obtained with a
concentration of 50 AM genistein. No osmotic alteration is
observable in the control curve obtained in the presence of
30 AM Ca2 + alone (dashed line). As observable in Fig. 3,
mitochondrial swelling is accompanied by dose-dependent
membrane depolarization (panel A) and release of accumu-
lated Ca2 + (panel B). All these effects induced by 50 AM
genistein are almost completely blocked by 1 AM cyclo-
sporin A (CsA) and 5 AM bongkrekic acid (BKA), two
typical inhibitors of the MPT (see insets in Figs. 2 and 3),
suggesting that the mitochondrial changes are indicative of
MPT induction.
The presence of EGTA, a calcium chelator, or ruthenium
red, an inhibitor of mitochondrial Ca2 + uptake, prevents the
genistein-induced absorbance change (Fig. 4), suggesting
that Ca2 + is necessary for induction of the MPT by
genistein. In the absence of added Ca2 +, genistein induces
swelling of low amplitude, which is completely prevented
by EGTA or ruthenium red (Fig. 4). This observation
suggests that genistein can induce the MPT, although to a
very reduced extent, by acting together with the contami-
nating Ca2 + in the medium (2–3 AM) and/or with the
endogenous Ca2 + (7 nmol/mg prot.) which cycles across
the inner membrane.
The redox state of mitochondrial thiols and pyridine
nucleotides is a parameter strictly involved in MPT induc-
tion, either through an amplifying or triggering effect. The
results reported in Fig. 5A show that the percentage of
reduced mitochondrial thiols in the control condition
(measured after 20 min of incubation), about 95% of the
total, decreases to a value of 65% in the presence of 50
AM genistein, demonstrating a 30% increase in the oxida-
tion of total thiols. Under the same conditions, pyridine
nucleotides are also intensively oxidized (Fig. 5B). These
oxidation phenomena are not observed in the presence of
CsA or BKA, indicating that they are strictly correlated
with induction of the MPT. However, as reported in Fig. 6,
it must be emphasized that dithiothreitol (DTT) and N-
ethylmaleimide (NEM) are also able to completely prevent
mitochondrial swelling, thus confirming that a shift in the
mitochondrial redox state towards a more oxidized level is
implicated in the opening of the transition pore by genis-
tein. These observations point out that genistein is able to
directly or indirectly generate reactive oxygen species
(ROS). In this regard, it is noteworthy that catalase
exhibits only a very slight inhibitory effect, as shown in
Fig. 6.
Due to their generation of incompletely reduced oxygen
intermediates, e.g. superoxide radicals (O2
S), hydrogen
peroxide (H2O2), or hydroxyl radicals (OH
S) [6], mitochon-
dria represent the main source of ROS production in the cell
under physiological conditions. Therefore, we next inves-
tigated whether the interaction of genistein with the mito-
chondrial respiratory chain might result in increased ROS
production. Fig. 7 shows that the addition of genistein to a
mitochondrial suspension induces an increase in H2O2
Fig. 4. Effect of EGTA and ruthenium red on swelling induced by genistein. Assays were carried out in standard medium in the absence (Ca2 +) or presence
of 30 AM Ca2 +. Genistein (50 AM), EGTA (1 mM) and ruthenium red (RR, 0.5 AM) were added as indicated. The assays were performed five times with
comparable results.
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formation up to 0.8 nmol/0.5 mg prot., thus supporting this
hypothesis. In this regard, it must be pointed out that the
addition of catalase has virtually no effect on the MPT (Fig.
6). These observations would indicate that H2O2 is not the
ROS mainly involved in the MPT induced by genistein. Fig.
7 also shows that the increase in H2O2 formation by
genistein is partially inhibited by CsA or BKA. This result
is explainable by taking into account the observation of Fig.
4 in which genistein is able to induce the MPT, albeit to a
very low extent, by utilizing contaminating Ca2 + in the
medium and/or the cycling of endogenous Ca2 +. The
amount of H2O2 produced in the presence of CsA or
BKA should be ascribable to the interaction of genistein
with the respiratory chain. This amount would account for
Fig. 5. Oxidation of mitochondrial thiols (A) and pyridine nucleotides (B) induced by genistein. RLM were incubated as in Fig. 1, with 50 AM genistein, 1 mM
EGTA, 1 AM CsA or 5 AM BKA added as indicated. Protein sulfhydryl oxidation was measured after 20 min of incubation. The mean values for thiol
oxidationF S.D. from six experiments are reported (A). Six additional assays for pyridine nucleotide oxidation exhibited the same trend in fluorescence change
(B). The inset reports a parallel quantitative determination of pyridine nucleotide oxidation performed by the methylethylketone method [20]. The mean values
from three experimentsF S.D. are reported.
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the low level of MPT induction. In this regard, it has been
reported that the transition pore may have a number of
intermediate conformations between fully closed and open
[22] that are responsible for gradual changes in permeability
of the inner membrane [23]. The production of H2O2 by
genistein is not increased in the presence of 30 AM Ca2 +
(results not reported), suggesting that the generation of other
ROS is favoured due to the enhanced activity of the
respiratory chain in this condition. This proposal is strongly
supported by the negligible effect of catalase on the MPT
observed in Fig. 6.
The results reported in Fig. 8 show the effects of
different respiratory chain electron donors (3-hydroxybu-
tyrate, succinate and ascorbate plus N,N,NV,NV-tetramethyl-
p-phenylendiamine (TMPD)) and inhibitors (rotenone and
antimycin A) on the MPT induced by genistein. These
analyses permitted us to determine the effect of the
respiratory chain components’ redox state on the phenom-
enon and to identify the complex involved in the inter-
action with genistein.
We observed that genistein is able to induce the MPT in
mitochondria energized by succinate plus rotenone in the
presence of 3-hydroxybutyrate, which under these condi-
tions strongly reduces the components of Complex I. The
rate and extent of swelling (curve a, panel A) and the trend
in DW collapse (curve a, panel B) are identical to those
observed in the absence of 3-hydroxybutyrate (curve b in
panels A and B; also see Figs. 2, 4, and 6).
Addition of antimycin A to the 3-hydroxybutyrate-
treated mitochondria blocks genistein-induced swelling
(curve c, panel A). It is to be underlined that, by blocking
electron flow through Complex III (cyt. bc1 complex),
antimycin A deenergizes mitochondria (curve c, panel B)
and shifts the respiratory chain components lying upstream
of its interaction site towards a completely reduced state.
Re-energization of these mitochondria by ascorbate plus
TMPD (curve cV, panel B) is ineffective in re-inducing the
swelling phenomenon (curve cV, panel A).
A different picture is observed when mitochondria are
energized only by ascorbate plus TMPD instead of succi-
nate plus rotenone. In this case, genistein is able to trigger
the MPT both in the absence and presence of 3-hydrox-
ybutyrate plus rotenone (see curves d and e, respectively,
in both panels). The different time-course of MPT induc-
tion observed in these conditions compared with those of
curves a and b is likely ascribable to differences in the
Ca2 + threshold required to induce the phenomenon when
mitochondria are energized with different respiratory sub-
strates [24].
These results point out that MPT induction by genistein
is completely prevented when Complex I and Complex III
Fig. 6. Effect of DTT, NEM and catalase on mitochondrial swelling induced by genistein. RLM were incubated as in Fig. 1 with 50 AM genistein, 1 mM DTT,
10 AM NEM, 1000 U/mg prot catalase added as indicated. Shown is a typical experiment; five additional experiments yielded comparable results.
Fig. 7. Mitochondrial hydrogen peroxide production in the presence of
genistein. RLM were incubated in standard medium in the presence of 0.9
mM homovanillic acid and 9 U/ml horseradish peroxidase with or without
50 AM genistein; 1 AM CsA or 5 AM BKA was added as indicated. The
mean values from four experimentsF S.D. are reported.
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(upstream of the inhibitory site of antimycin A) of the
respiratory chain are in a reduced state.
4. Discussion
The results presented in this study show that treatment of
RLM with a physiologically achievable concentration of
genistein (50 AM, see Ref. [25]) results in dose-dependent
matrix swelling, DW collapse, release of pre-accumulated
calcium and oxidation of thiol groups and pyridine nucleo-
tides (see Figs. 2–6). All these events are inhibited by the
endecapeptide immunosuppressant CsA, a ligand of mito-
chondrial cyclophilin [26], and by BKA, an inhibitor of the
adenine nucleotide translocase [27] (Figs. 2 and 3); both
compounds are typical inhibitors of MPT induction [28].
Furthermore, EGTA and ruthenium red also exhibit a strong
inhibitory effect on genistein-induced swelling, indicative of
a strict Ca2 + dependence of the phenomenon (Fig. 4A). All
the above-described experimental observations lead to the
conclusion that genistein behaves as a typical MPT inducer.
The oxidation of mitochondrial thiols and pyridine
nucleotides reported in Fig. 5A,B is consistent with the
involvement of oxidative stress in the phenomenon induced
by genistein.
The proposed mechanism is that genistein acts as a
prooxidant [14–16] producing ROS, most likely hydroxyl
radicals, through its direct reaction with the transition metals
of the respiratory chain and O2. In this regard, Cao et al.
[14] have proposed a reaction sequence for ROS production
Fig. 8. Effects of different redox states of the respiratory chain complexes and of different membrane energizing substrates on mitochondrial swelling (A) and
DW (B) induced by genistein. Continuous lines refer to RLM incubated in standard medium in the presence of 30 AM Ca2 + (energization by succinate plus
rotenone). Dashed lines refer to RLM incubated in standard medium deprived of succinate and rotenone and supplemented with ascorbate plus TMPD in the
presence of 30 AM Ca2 + (energization by ascorbate plus TMPD). Fifty-micromolar genistein (gen.), 5 mM 3-hydroxybutyrate (3Hb), 10 mM ascorbate (Asc.)
plus 100 AM TMPD, 1 AM antimycin A (Ant. A) and 1.25 AM rotenone (Rot.) were added as indicated. Controls refer to RLM energized with either succinate
plus rotenone or ascorbate plus TMPD plus 30 AM Ca2 + and without any other additions. The assays were performed five times with comparable results.
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by flavonoids whose first step requires the oxidized state of
the involved transition metal, which is reduced by reacting
with the flavonoid in reduced form.
Two complexes of the respiratory chain were shown to
be responsible for much of the ROS generated by mito-
chondria in physiological conditions [29–31] or in the
presence of drugs [32–35]: Complex I, the NADH ubiq-
uinone oxidoreductase, and Complex III, the ubiquinol-
cytochrome c oxidoreductase.
The generation of hydrogen peroxide can be accounted
for by the following reaction sequences [14]:
2Fe3
þ þ GEN OH! 2Fe2þ þ GEN ¼ Oþ Hþ
2Fe2
þ þ O2 X FeO2þ2
FeO2þ2 þ Fe2þ þ 2Hþ ! 2Fe3þ þ H2O2
where GEN-OH is the reduced form of genistein, GEN=O
is the oxidized form and Fe3+/2 + is an Fe–S belonging to the
involved respiratory complex. It is possible that genistein,
after its oxidation by the respiratory chain, is reduced by
diaphorase, a phenomenon previously demonstrated for
menadione [36].
The results reported in Fig. 8 show that genistein is able
to induce the MPT when mitochondria are energized with
either succinate plus rotenone or with ascorbate plus TMPD.
In both these conditions, the presence of 3-hydroxybu-
tyrate (plus rotenone when RLM are energized with ascor-
bate plus TMPD), which strongly reduces the components
of Complex I, does not alter the effects of genistein. By
taking into account the above-mentioned proposal that the
first step of the genistein prooxidant mechanism involves
the transition metal in the oxidized state [14], these results
indicate that the Fe–Ss of Complex I are not involved in the
interaction. Fig. 8 also shows that the addition of antimycin
A to 3-hydroxybutyrate-treated, succinate-plus-rotenone
energized RLM completely prevents MPT induction by
genistein.
This observation is explained by taking into account the
effect of the inhibitor on the respiratory chain. Antimycin A
blocks electron flow between the bH heme and, alternatively,
the ubiquinone or ubisemiquinone anion at the Qn (also
called Qi) site (see the Q cycle [37]), resulting in deenerg-
ization (Fig. 8B) and prevention of the MPT. It must be kept
in mind that both the bL and bH hemes are reduced under
these conditions. While subsequent addition of ascorbate
plus TMPD to this assay reenergizes the RLM (Fig. 8B), the
MPT does not occur. This result demonstrates that the
components belonging to the bc1 complex downstream of
the site of antimycin A inhibition, i.e., Rieske protein and
cyt c1, which have their transition metals in an oxidized
state, are not involved in the phenomenon. Therefore, the
target site must lie upstream of the site of antimycin A
inhibition in the segment comprising the bL and bH hemes.
This proposal is further confirmed by the results obtained
with RLM energized only by ascorbate plus TMPD. Under
this conditions, the presence of 3-hydroxybutyrate plus
rotenone, which reduces the four iron–sulfur clusters of
Complex I but leaves the cyt bc1 complex oxidized, does not
affect the ability of genistein to promote the MPT.
All these observations demonstrate that genistein acts
either on the Fe3 + of bL or on the bH heme of the cyt bc1
complex. Given the standard redox potentials of bL and bH
( 100 and + 50 mV, respectively), and considering that the
redox potential of flavonoids is in the range of  30 to + 60
mV [16], we can hypothesize that the target of genistein is
the Fe3 + of the bH heme.
Previous papers reported that flavonoids can exhibit
either antioxidant or prooxidant effects, depending on the
presence of a source of ROS together with a transition
metal. In this regard, genistein would appear to be peculiar
in exhibiting only the prooxidant effect, as the swelling of
RLM incubated in the presence of Ca2 + plus tert-butylhy-
droperoxide remains unaffected in the presence of genistein
(results not reported).
The hydroxyl group of genistein involved in the ROS-
producing reaction is most likely that in the 4Vposition (see
Fig. 1), as the 5 and 7 hydroxyls lie in reciprocal unreacting
meta positions.
The increase in H2O2 production in the presence of
genistein reported in Fig. 7, while modest, is also compat-
ible with the low or high amplitude swelling observed in the
absence or presence of added 30 AM Ca2 +, respectively (see
Fig. 4). In this regard, other observations have demonstrated
that similar small amounts of H2O2 are able to induce the
MPT [38,39]. The scarce protective effect exhibited by
catalase on MPT induction (Fig. 6) raises some doubt about
likelihood for direct intervention of H2O2. One possible
explanation is that H2O2, which is generated in the prox-
imity of the Qn center near the internal side of the mem-
brane, does not rapidly diffuse towards the outer site and
cannot interact with catalase. Another possibility is that
genistein favours the rapid formation of the highly reactive
hydroxyl radical as also previously reported [14] and that
this ROS is the main molecule responsible for the observed
effects. The involvement of this radical has also been
proposed for other inducers [40]. Although oxidative stress
has long been known to be involved in MPT induction and/
or modulation, its precise mechanism is not yet clear.
Previous results suggested that the MPT occurs due to the
direct oxidation of critical membrane thiol groups induced
by respiratory chain-generated ROS [41–43] in the presence
of Ca2 +. It has been proposed that two sites are the targets of
oxidants and reductants [44]. The first site, named the ‘‘S’’
site, is a dithiol, while the second site, named the ‘‘P’’ site, is
chemically undefined. The oxidation of these sites by small
amounts of ROS produced by genistein would open the
transition pore, while their reduction by DTE or NEM
would favour its closure. The opening of the transition pore
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results in substantial ROS production with consequent
oxidation of the pyridine nucleotide pool and mitochondrial
thiols [45]. This sequence of events explains the protective
effects of DTE and NEM (Fig. 6).
Alternatively, ROS produced by genistein could induce
an acceleration of Ca2 + cycling followed by the oxidation
of pyridine nucleotides [46]. In this regard, it has been
demonstrated that oxidized pyridine nucleotides are hydro-
lyzed by an NAD-hydrolase and the reaction product,
ADP-ribose, opens a new specific pathway for Ca2 + efflux
which enhances Ca2 + cycling. This phenomenon would
further increase mitochondrial ROS formation [45] with
catastrophic effects on the insulating properties of the
inner membrane that would affect its bioenergetics
capacity [45].
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